pharmaphorum2d
Sanofi makes another pipeline deal, tapping Adagene for antibody tech
The Chinese company is deploying the technology in its in-house pipeline in AG126, an antibody prodrug targeting the immune checkpoint CTLA4. That's the same target as Bristol-Myers Squibb's ...
Nasdaq1mon
NAYA Biosciences Expands Bifunctional Antibody Pipeline with PD-1 x VEGF Candidate for Oncology Applications
NAYA Biosciences has announced the expansion of its bifunctional antibody pipeline to include a novel PD-1 x VEGF tetravalent antibody, NY-500, targeted at hepatocellular carcinoma (HCC ...
Business Insider1mon
ImmunoPrecise Antibodies realigns pipeline strategy, AI-powered pipeline
ImmunoPrecise Antibodies (IPA) announced the launch of its AI-powered pipeline of both optimized and new therapeutics. By combining advanced artificial intelligence with first-principles thinking ...
Morningstar1mon
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set to transform therapeutic development.
Nasdaq1mon
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
complementing the Company’s anti-CD19 antibody, budoprutug. "Adding CLYM116 to our pipeline represents a pivotal moment for Climb Bio as we advance our ambition of becoming a leader in ...
Business Insider1mon
iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs.